Washington University, MO, USA
Brad Kahl, MD
Brad Kahl, MD, is a professor of medicine and director of the lymphoma program at Washington University School of Medicine, St. Louis. He earned his medical degree from Tufts University School of Medicine, Boston. He then completed a residency in internal medicine, a year as chief resident, and a fellowship in hematology at the University of Wisconsin (UW).
Dr. Kahl’s research focuses on improving outcomes for patients with lymphoma through testing novel agents in well-designed clinical trials. He is Chair of the ECOG-ACRIN lymphoma committee since 2009 where he has facilitated the development of multiple large clinical trials. Dr. Kahl is a member of several professional societies, including the American Society of Hematology, American Society of Clinical Oncology, ECOG-ACRIN, US Food and Drug Administration Oncologic Drugs Advisory Committee, and the National Cancer Institute Lymphoma Steering Committee. He is a member of the Lymphoma Research Foundation Scientific Advisory Board and served as Chair of the LRF Mantle Cell Lymphoma Consortium from 2012-2018.